Tags

Type your tag names separated by a space and hit enter

"Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria.
BMC Public Health. 2015 Apr 10; 15:349.BP

Abstract

BACKGROUND

Nigeria has the second highest number of new HIV infections annually. Therefore, it is important to explore new strategies for preventing new infections. The introduction of pre-exposure prophylaxis (PrEP) for use by persons at high risk of HIV infection has new potential in preventing new HIV infections. The aim of this study is to explore the public opinion, community interest, and perceptions about the use and access to PrEP in Nigeria.

METHODS

This formative study used a mixed method approach to collect data on public opinions and perceptions on appropriate target groups for PrEP access, community interest, perceptions about the use of PrEP as an HIV-prevention tool, how best to communicate with participants about PrEP, concerns about PrEP use by serodiscordant couples, and suggestions for the design and implementation of a PrEP demonstration project. Telephone and in-depth interviews were conducted, and focus group discussions and consultative meetings were held with critical stakeholders engaged in HIV-prevention, treatment, care, and support programmes in Nigeria. An online survey was also conducted.

RESULTS

HIV serodiscordant couples were identified as the appropriate target group for PrEP use. Most respondents felt that PrEP use by key affected populations would help reduce the HIV incidence. Stigma was identified as a major concern and a potential barrier for the acceptance and use of PrEP by HIV serodiscordant couples. Electronic and print media were identified as important means for massive public education to prevent stigma and create awareness about PrEP. In a male dominated society such as Nigeria, HIV-negative male partners in serodiscordant relationships may resist enrolment in PrEP programmes. This may be complicated by the fact that the identified index partner in most serodiscordant relationships in Nigeria is an HIV-positive woman, who is often diagnosed during pregnancy.

CONCLUSIONS

PrEP uptake and use by HIV serodiscordant couples in Nigeria may face notable but surmountable challenges. Much depends on the appropriateness of actions taken by multiple players. Motivation of HIV-negative male partners to use PrEP and establishment of effective public education programmes in addressing stigma are essential.

Authors+Show Affiliations

National Agency for the Control of AIDS, Abuja, Nigeria. jonidoko@yahoo.com.Department of Child Dental Health, Obafemi Awolowo University, Ile-Ife, Nigeria. toyinukpong@yahoo.co.uk. New HIV Vaccine and Microbicide Advocacy Society, Lagos, Nigeria. toyinukpong@yahoo.co.uk. Institute of Public Health, Obafemi Awolowo University, Ile-Ife, Nigeria. toyinukpong@yahoo.co.uk.Department of AIDS Prevention Initiative Nigeria (APIN), Jos University Teaching Hospital, Jos, Nigeria. nancindadem@yahoo.com.Department of AIDS Prevention Initiative Nigeria (APIN), Jos University Teaching Hospital, Jos, Nigeria. gracehupa@yahoo.com.National Agency for the Control of AIDS, Abuja, Nigeria. anenihj15@yahoo.com.National Agency for the Control of AIDS, Abuja, Nigeria. eoalhassan@gmail.com.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

25881087

Citation

Idoko, John, et al. ""Why Should I Take Drugs for Your Infection?": Outcomes of Formative Research On the Use of HIV Pre-exposure Prophylaxis in Nigeria." BMC Public Health, vol. 15, 2015, p. 349.
Idoko J, Folayan MO, Dadem NY, et al. "Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria. BMC Public Health. 2015;15:349.
Idoko, J., Folayan, M. O., Dadem, N. Y., Kolawole, G. O., Anenih, J., & Alhassan, E. (2015). "Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria. BMC Public Health, 15, 349. https://doi.org/10.1186/s12889-015-1690-9
Idoko J, et al. "Why Should I Take Drugs for Your Infection?": Outcomes of Formative Research On the Use of HIV Pre-exposure Prophylaxis in Nigeria. BMC Public Health. 2015 Apr 10;15:349. PubMed PMID: 25881087.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - "Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria. AU - Idoko,John, AU - Folayan,Morenike Oluwatoyin, AU - Dadem,Nancin Yusufu, AU - Kolawole,Grace Oluwatosin, AU - Anenih,James, AU - Alhassan,Emmanuel, Y1 - 2015/04/10/ PY - 2014/04/12/received PY - 2015/03/26/accepted PY - 2015/4/17/entrez PY - 2015/4/17/pubmed PY - 2016/2/9/medline SP - 349 EP - 349 JF - BMC public health JO - BMC Public Health VL - 15 N2 - BACKGROUND: Nigeria has the second highest number of new HIV infections annually. Therefore, it is important to explore new strategies for preventing new infections. The introduction of pre-exposure prophylaxis (PrEP) for use by persons at high risk of HIV infection has new potential in preventing new HIV infections. The aim of this study is to explore the public opinion, community interest, and perceptions about the use and access to PrEP in Nigeria. METHODS: This formative study used a mixed method approach to collect data on public opinions and perceptions on appropriate target groups for PrEP access, community interest, perceptions about the use of PrEP as an HIV-prevention tool, how best to communicate with participants about PrEP, concerns about PrEP use by serodiscordant couples, and suggestions for the design and implementation of a PrEP demonstration project. Telephone and in-depth interviews were conducted, and focus group discussions and consultative meetings were held with critical stakeholders engaged in HIV-prevention, treatment, care, and support programmes in Nigeria. An online survey was also conducted. RESULTS: HIV serodiscordant couples were identified as the appropriate target group for PrEP use. Most respondents felt that PrEP use by key affected populations would help reduce the HIV incidence. Stigma was identified as a major concern and a potential barrier for the acceptance and use of PrEP by HIV serodiscordant couples. Electronic and print media were identified as important means for massive public education to prevent stigma and create awareness about PrEP. In a male dominated society such as Nigeria, HIV-negative male partners in serodiscordant relationships may resist enrolment in PrEP programmes. This may be complicated by the fact that the identified index partner in most serodiscordant relationships in Nigeria is an HIV-positive woman, who is often diagnosed during pregnancy. CONCLUSIONS: PrEP uptake and use by HIV serodiscordant couples in Nigeria may face notable but surmountable challenges. Much depends on the appropriateness of actions taken by multiple players. Motivation of HIV-negative male partners to use PrEP and establishment of effective public education programmes in addressing stigma are essential. SN - 1471-2458 UR - https://www.unboundmedicine.com/medline/citation/25881087/"Why_should_I_take_drugs_for_your_infection":_outcomes_of_formative_research_on_the_use_of_HIV_pre_exposure_prophylaxis_in_Nigeria_ L2 - https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-015-1690-9 DB - PRIME DP - Unbound Medicine ER -